Skip to main content

Articles

208 result(s) within Volume 12 of Radiation Oncology

Page 1 of 5

  1. Hypoxia-induced radioresistance constitutes a major obstacle for a curative treatment of cancer. The aim of this study was to investigate effects of photon and carbon ion irradiation in combination with inhibi...

    Authors: Carmen Klein, Ivana Dokic, Andrea Mairani, Stewart Mein, Stephan Brons, Peter Häring, Thomas Haberer, Oliver Jäkel, Astrid Zimmermann, Frank Zenke, Andree Blaukat, Jürgen Debus and Amir Abdollahi
    Citation: Radiation Oncology 2017 12:208
  2. Postoperative radiation (PORT) is an option for non-small cell lung cancer (NSCLC) patients with resectable stage IIIA pathological N2 status (pN2). For patients with PORT, this study aims to investigate the i...

    Authors: Siwei Wang, Zhifei Ma, Xiangbao Yang, Yajing Wang, Youtao Xu, Wenjia Xia, Rui Chen, Mantang Qiu, Feng Jiang, Rong Yin, Lin Xu and Keping Xu
    Citation: Radiation Oncology 2017 12:207
  3. Tumor Treating Fields (TTFields) are an anti-neoplastic treatment modality delivered via application of alternating electric fields using insulated transducer arrays placed directly on the skin in the region s...

    Authors: Moshe Giladi, Mijal Munster, Rosa S. Schneiderman, Tali Voloshin, Yaara Porat, Roni Blat, Katarzyna Zielinska-Chomej, Petra Hååg, Ze’ev Bomzon, Eilon D. Kirson, Uri Weinberg, Kristina Viktorsson, Rolf Lewensohn and Yoram Palti
    Citation: Radiation Oncology 2017 12:206
  4. Preclinical radiation biology has become increasingly sophisticated due to the implementation of advanced small animal image guided radiation platforms into laboratory investigation. These small animal radioth...

    Authors: Mihaela Ghita, Stephen J. McMahon, Hannah F. Thompson, Conor K. McGarry, Raymond King, Sarah O. S. Osman, Jonathan L. Kane, Amanda Tulk, Giuseppe Schettino, Karl T. Butterworth, Alan R. Hounsell and Kevin M. Prise
    Citation: Radiation Oncology 2017 12:204
  5. Pancreatic cancer, especially in case of locally advanced stage has a poor prognosis. Radiotherapy in general can lead to tumor volume reduction, but further improvements, such as ion beam therapy have to be p...

    Authors: Constantin Dreher, Daniel Habermehl, Oliver Jäkel and Stephanie E. Combs
    Citation: Radiation Oncology 2017 12:203
  6. Cisplatin and gemcitabine combined with conventional radiation therapy in the treatment of cervical cancer patients results in a favorable outcome but with excess toxicity. The purpose of this study was to eva...

    Authors: Nikola Cihoric, Alexandros Tsikkinis, Eugenia Vlaskou Badra, Markus Glatzer, Urban Novak, Amina Scherz, Mohamed Shelan, Ivan Soldatovic, Chittazhathu Kurian Kuruvilla Yojena, Daniel M. Aebersold and Kristina Lössl
    Citation: Radiation Oncology 2017 12:202
  7. Our previous studies showed that vasoconstrictor applied topically to rat skin minutes before irradiation completely prevented radiodermatitis. Here we report on a Phase IIa study of topically applied NG12-1 v...

    Authors: James F. Cleary, Bethany M. Anderson, Jens C. Eickhoff, Deepak Khuntia and William E. Fahl
    Citation: Radiation Oncology 2017 12:201
  8. The aim of this review is the critical appraisal of the current use of volumetric modulated arc therapy for the radiation therapy management of breast cancer. Both clinical and treatment planning studies were ...

    Authors: Luca Cozzi, Frank Lohr, Antonella Fogliata, Davide Franceschini, Fiorenza De Rose, A R Filippi, Gabriele Guidi, Valentina Vanoni and Marta Scorsetti
    Citation: Radiation Oncology 2017 12:200
  9. The internal mammary (IM) lymph node chain, along with the axillary nodal basin, is a first-echelon breast lymphatic draining site. A growing body of evidence supports irradiation of this region in node-positi...

    Authors: Sean Sachdev, Chelain R. Goodman, Erin Neuschler, Kapila Kalakota, Daniel Cutright, Eric D. Donnelly, John P. Hayes, Adam E. Prescott, Gianna Mirabelli and Jonathan B. Strauss
    Citation: Radiation Oncology 2017 12:199
  10. Peri-operative radiation of retroperitoneal sarcomas (RPS) is an important component of multidisciplinary treatment. All retrospective series thus far included patients treated with older radiation therapy (RT...

    Authors: Pippa F. Cosper, Jeffrey Olsen, Todd DeWees, Brian A. Van Tine, William Hawkins, Jeff Michalski and Imran Zoberi
    Citation: Radiation Oncology 2017 12:198
  11. The optimization of the management for elderly glioblastoma patients is crucial given the demographics of aging in many countries. We report the outcomes for a “real-life” patient cohort (i.e. unselected) comp...

    Authors: J. Biau, E. Chautard, E. De Schlichting, G. Dupic, B. Pereira, A. Fogli, M. Müller-Barthélémy, P. Dalloz, T. Khalil, A. F. Dillies, X. Durando, C. Godfraind and P. Verrelle
    Citation: Radiation Oncology 2017 12:197
  12. To compare organ-at-risk doses and setup reproducibility using the prone and supine orientations in volumetric modulated arc therapy (VMAT) for rectal cancer.

    Authors: Anthony Kim, Aliaksandr Karotki, Joe Presutti, Glen Gonzales, Shun Wong and William Chu
    Citation: Radiation Oncology 2017 12:180
  13. To evaluate the role of radiotherapy (RT) as an adjuvant or definitive treatment in primary tracheal adenoid cystic carcinoma (ACC) for local tumor control and survival.

    Authors: Hyoung Uk Je, Si Yeol Song, Dong Kwan Kim, Yong-Hee Kim, Seong-Yun Jeong, Geum Mun Back, Wonsik Choi, Su Ssan Kim, Seung-Il Park and Eun Kyung Choi
    Citation: Radiation Oncology 2017 12:196
  14. Heath-related quality of life (HRQoL) among survivors with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC) treated with radiotherapy and chemotherapy still is not clear. The current study w...

    Authors: Juntao Ran, Jingbo Wang, Nan Bi, Wei Jiang, Zongmei Zhou, Zhouguang Hui, Jun Liang, Qinfu Feng and Luhua Wang
    Citation: Radiation Oncology 2017 12:195
  15. To investigate radiation oncologists’ opinions on important considerations to offering re-irradiation (re-RT) as a treatment option for recurrent glioma.

    Authors: Andra V. Krauze, Albert Attia, Steve Braunstein, Michael Chan, Stephanie E. Combs, Rainer Fietkau, John Fiveash, John Flickinger, Anca Grosu, Steven Howard, Carsten Nieder, Maximilian Niyazi, Lindsay Rowe, Dee Dee Smart, Christina Tsien and Kevin Camphausen
    Citation: Radiation Oncology 2017 12:194

    The Correction to this article has been published in Radiation Oncology 2018 13:8

  16. The rapid rise of particle therapy across the world necessitates evidence to justify its ever-increasing utilization. This narrative review summarizes the current status of these technologies on treatment of b...

    Authors: Sebastian Adeberg, Semi B. Harrabi, Vivek Verma, Denise Bernhardt, Nicole Grau, Jürgen Debus and Stefan Rieken
    Citation: Radiation Oncology 2017 12:193
  17. The purpose of this study was to investigate the differences in the dosimetric advantage of using intraoperatively built custom-linked (IBCL) seeds between permanent iodine-125 (I-125) seed implantation (PI) a...

    Authors: Katsumi Hirose, Masahiko Aoki, Mariko Sato, Hiroyoshi Akimoto, Yasuhiro Hashimoto, Atsushi Imai, Noritaka Kamimura, Hideo Kawaguchi, Yoshiomi Hatayama, Ichitaro Fujioka, Mitsuki Tanaka, Chikara Ohyama and Yoshihiro Takai
    Citation: Radiation Oncology 2017 12:192
  18. Despite mounting evidence for the use of re-irradiation (re-RT) in recurrent high grade glioma, optimal patient selection criteria for re-RT remain unknown. We present a novel scoring system based on radiobiol...

    Authors: Andra Valentina Krauze, Cord Peters, Jason Cheng, Holly Ning, Megan Mackey, Lindsay Rowe, Theresa Cooley-Zgela, Dee Dee Smart and Kevin Camphausen
    Citation: Radiation Oncology 2017 12:191
  19. Proton beam therapy is promising for the treatment of head and neck cancer (HNC), but it is sensitive to uncertainties in patient positioning and particle range. Studies have shown that the planning target vol...

    Authors: Macarena Cubillos-Mesías, Michael Baumann, Esther G. C. Troost, Fabian Lohaus, Steffen Löck, Christian Richter and Kristin Stützer
    Citation: Radiation Oncology 2017 12:190
  20. Intrafractional motion can be a substantial uncertainty in precision radiotherapy. Conventionally, the target volume is expanded to account for the motion. Couch-tracking is an alternative, where the patient i...

    Authors: Alexander Jöhl, Marta Bogowicz, Stefanie Ehrbar, Matthias Guckenberger, Stephan Klöck, Mirko Meboldt, Oliver Riesterer, Melanie Zeilinger, Marianne Schmid Daners and Stephanie Tanadini-Lang
    Citation: Radiation Oncology 2017 12:189
  21. The prognosis for patients with cervical or endometrial cancer has improved over the last decades. Thus, reducing therapy-related toxicity and impact on quality of life have become more and more important. Wit...

    Authors: N. Arians, K. Lindel, J. Krisam, K. Herfarth, D. Krug, S. Akbaba, J. Oelmann-Avendano and J. Debus
    Citation: Radiation Oncology 2017 12:188
  22. This work explores how the choice of prescription isodose line (IDL) affects the dose gradient, target coverage, and treatment time for Gamma Knife radiosurgery when a smaller shot is encompassed within a larg...

    Authors: Perry B. Johnson, Maria I. Monterroso, Fei Yang and Eric Mellon
    Citation: Radiation Oncology 2017 12:187
  23. In the original publication [1] the name of author Jeremy M. Aymard was spelled wrong. The original article was updated to rectify this error.

    Authors: Salman A. Eraj, Mona K. Jomaa, Crosby D. Rock, Abdallah S. R. Mohamed, Blaine D. Smith, Joshua B. Smith, Theodora Browne, Luke C. Cooksey, Bowman Williams, Brandi Temple, Kathryn E. Preston, Jeremy M. Aymard, Neil D. Gross, Randal S. Weber, Amy C. Hessel, Renata Ferrarotto…
    Citation: Radiation Oncology 2017 12:186

    The original article was published in Radiation Oncology 2017 12:150

  24. The skin is considered a critical organ at risk in carbon ion radiotherapy (CIRT) for locally advanced malignant bone and soft tissue tumors (MBSTs). The predictive factors for acute skin reactions after CIRT ...

    Authors: Yosuke Takakusagi, Jun-ichi Saitoh, Hiroki Kiyohara, Takahiro Oike, Shin-ei Noda, Tatsuya Ohno and Takashi Nakano
    Citation: Radiation Oncology 2017 12:185
  25. To investigate the advantage of concurrent chemotherapy with postoperative radiotherapy (RT) of oral squamous cell carcinoma (OSCC) in patients with three or more minor risk factors.

    Authors: Kang-Hsing Fan, Yen-Chao Chen, Chien-Yu Lin, Chung-Jan Kang, Li-Yu Lee, Shiang-Fu Huang, Chun-Ta Liao, Shu-Hang Ng, Hung-Ming Wang and Joseph Tung-Chieh Chang
    Citation: Radiation Oncology 2017 12:184
  26. Pancreatic cancer has a dismal prognosis with 5-year overall survival rate of around 5%. Although surgery is still the best option in operable cases, majority of the patients who present in locally advanced st...

    Authors: Niloy Ranjan Datta, Bernhard Pestalozzi, Pierre-Alain Clavien, Alexander Siebenhüner, Emsad Puric, Shaka Khan, Christoph Mamot, Oliver Riesterer, Jürg Knuchel, Cäcilia Sophie Reiner and Stephan Bodis
    Citation: Radiation Oncology 2017 12:183
  27. Neoadjuvant chemoradiation (nCRT) is the treatment of choice for patients with locally advanced squamous cell carcinoma of the esophagus (SCC). Today radiation oncologists can choose between two different ther...

    Authors: Stefan Münch, Steffi U. Pigorsch, Marcus Feith, Julia Slotta-Huspenina, Wilko Weichert, Helmut Friess, Stephanie E. Combs and Daniel Habermehl
    Citation: Radiation Oncology 2017 12:182
  28. To investigate the feasibility of using dual-energy CT (DECT) for tissue segmentation and kilovolt (kV) dose calculations in pre-clinical studies and assess potential dose calculation accuracy gain.

    Authors: Ana Vaniqui, Lotte E. J. R. Schyns, Isabel P. Almeida, Brent van der Heyden, Stefan J. van Hoof and Frank Verhaegen
    Citation: Radiation Oncology 2017 12:181
  29. SCOPE 1 was the first UK based multi-centre trial involving radiotherapy of the oesophagus. A comprehensive radiotherapy trials quality assurance programme was launched with two main aims:

     

    Authors: Lucy Wills, Rhydian Maggs, Geraint Lewis, Gareth Jones, Lisette Nixon, John Staffurth and Tom Crosby
    Citation: Radiation Oncology 2017 12:179
  30. The aim of this study was to report outcomes and late toxicity following hypofractionated accelerated radiotherapy for T2 glottic cancers. We highlight the importance of hypofractionated treatments with shorte...

    Authors: Lynne M. Dixon, Catriona M. Douglas, Shazril Imran Shaukat, Kate Garcez, Lip Wai Lee, Andrew J. Sykes, David Thomson and Nicholas J. Slevin
    Citation: Radiation Oncology 2017 12:178
  31. We compared the functional outcome and influential factors of two standard treatment modalities for central cerebral metastases: electrophysiological-controlled microsurgical resection (MSR) and stereotactic r...

    Authors: Bogdan Pintea, Brigitta Baumert, Thomas Mehari Kinfe, Konstantinos Gousias, Yaroslav Parpaley and Jan Patrick Boström
    Citation: Radiation Oncology 2017 12:177
  32. To determine the potential role of 68Ga-PSMA positron emission tomography/computed tomography (PET/CT) in radiotherapy (RT) planning for prostate cancer (PCa).

    Authors: Nina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Alexander Buchner, Christian Stief, Paul Rogowski, Maximilian Niyazi, Chukwuka Eze, Minglun Li, Peter Bartenstein, Claus Belka and Ute Ganswindt
    Citation: Radiation Oncology 2017 12:176
  33. Radiotherapy for pancreatic cancer has two major challenges: (I) the tumor is adjacent to several critical organs and, (II) the mobility of both, the tumor and its surrounding organs at risk (OARs). A treatmen...

    Authors: Konstantina Karava, Stefanie Ehrbar, Oliver Riesterer, Johannes Roesch, Stefan Glatz, Stephan Klöck, Matthias Guckenberger and Stephanie Tanadini-Lang
    Citation: Radiation Oncology 2017 12:175
  34. To summarize the research activities of the “clinical research group heavy ion therapy”, funded by the German Research Foundation (DFG, KFO 214), on the impact of intrinsic tumor characteristics (grading, hypo...

    Authors: Christin Glowa, Peter Peschke, Stephan Brons, Oliver C. Neels, Klaus Kopka, Jürgen Debus and Christian P. Karger
    Citation: Radiation Oncology 2017 12:174
  35. In the original publication [1] figure legends 2 and 4 have been swapped. The original article was updated to rectify this error.

    Authors: J. Krayenbuehl, M. Di Martino, M. Guckenberger and N. Andratschke
    Citation: Radiation Oncology 2017 12:173

    The original article was published in Radiation Oncology 2017 12:161

  36. Normal lung tissue tolerance constitutes a limiting factor in delivering the required dose of radiotherapy to cure thoracic and chest wall malignancies. Radiation-induced lung fibrosis (RILF) is considered a c...

    Authors: Cheng Zhou, Bleddyn Jones, Mahmoud Moustafa, Christian Schwager, Julia Bauer, Bing Yang, Liji Cao, Min Jia, Andrea Mairani, Ming Chen, Longhua Chen, Juergen Debus and Amir Abdollahi
    Citation: Radiation Oncology 2017 12:172
  37. Scanned ion beam therapy has special demands for treatment of intra-fractionally moving tumors such as lesions in lung or liver. Interplay effects between beam and organ motion can in those settings lead to un...

    Authors: Christoph Bert and Klaus Herfarth
    Citation: Radiation Oncology 2017 12:170
  38. For irradiation treatment planning of meningiomas the use of PET-scans is well established. The most frequently used tracers are either based on amino acids or the somatostatin receptor ligand DOTATOC. Since u...

    Authors: Jan Oliver Dittmar, Clemens Kratochwil, Anne Dittmar, Thomas Welzel, Daniel Habermehl, Stefan Rieken, Frederik L. Giesel, Uwe Haberkorn, Jürgen Debus and Stephanie E. Combs
    Citation: Radiation Oncology 2017 12:169
  39. The purpose of this study was to demonstrate the feasibility of physician driven planning in intensity modulated radiotherapy (IMRT) with a multicriteria optimization (MCO) treatment planning system and templa...

    Authors: Birgit S. Müller, Helen A. Shih, Jason A. Efstathiou, Thomas Bortfeld and David Craft
    Citation: Radiation Oncology 2017 12:168
  40. Radiation pneumonitis (RP) has been a challenging obstacle in treating stage III lung cancer patients. Beam angle optimization (BAO) technique for Tomotherapy was developed to reduce the normal lung dose for s...

    Authors: Chae-Seon Hong, Sang Gyu Ju, Yong Chan Ahn, Gyu Sang Yoo, Jae Myoung Noh, Dongryul Oh, Kwangzoo Chung, Hongryull Pyo and Kwanghyun Jo
    Citation: Radiation Oncology 2017 12:167
  41. The “gold standard” approach for defining an internal target volume (ITV) is using 10 gross tumor volume (GTV) phases delineated over the course of one respiratory cycle. However, different sites have adopted ...

    Authors: Dennis J. Mohatt, John M. Keim, Mathew C. Greene, Ami Patel-Yadav, Jorge A. Gomez and Harish K. Malhotra
    Citation: Radiation Oncology 2017 12:166
  42. Radiation pneumonitis (RP) is the most common subacute side effect after concurrent chemoradiotherapy (CRT) for locally advanced non-small cell lung cancer. Several clinical and dose-volume (DV) parameters are...

    Authors: Mohammed Alharbi, Stefan Janssen, Heiko Golpon, Michael Bremer and Christoph Henkenberens
    Citation: Radiation Oncology 2017 12:165
  43. The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been e...

    Authors: Jie Liu, Ye Zhang, Zhengjiang Li, Shaoyan Liu, Huizheng Li and Zhengang Xu
    Citation: Radiation Oncology 2017 12:164
  44. Stereotactic body radiotherapy (SBRT) is an emerging modality for definitive treatment of Hepatocellular carcinoma (HCC).

    Authors: Assaf Moore, Michal Cohen-Naftaly, Anna Tobar, Yulia Kundel, Ofer Benjaminov, Marius Braun, Assaf Issachar, Eytan Mor, Michal Sarfaty, Dimitri Bragilovski, Ran Ben Hur, Noa Gordon, Salomon M. Stemmer and Aaron M. Allen
    Citation: Radiation Oncology 2017 12:163
  45. Local treatment options for patients with in-field non-small cell lung cancer (NSCLC) recurrence following conventionally fractionated external beam radiation therapy (CF-EBRT) are limited. Stereotactic body r...

    Authors: Michael C. Repka, Nima Aghdam, Shaan K. Kataria, Lloyd Campbell, Simeng Suy, Sean P. Collins, Eric Anderson, Jonathan W. Lischalk and Brian T. Collins
    Citation: Radiation Oncology 2017 12:162
  46. Whole-brain radiation therapy (WBRT) with hippocampus sparing (HS) has been investigated by the radiation oncology working group (RTOG) 0933 trial for patients with multiple brain metastases. They showed a dec...

    Authors: J. Krayenbuehl, M. Di Martino, M. Guckenberger and N. Andratschke
    Citation: Radiation Oncology 2017 12:161

    The Correction to this article has been published in Radiation Oncology 2017 12:173

  47. The risk factors for radiation pneumonitis (RP) in patients with chronic obstructive pulmonary disease (COPD) are unclear. Mean lung dose (MLD) and percentage of irradiated lung volume are common predictors of...

    Authors: Yasuki Uchida, Takuya Tsugawa, Sachiko Tanaka-Mizuno, Kazuo Noma, Ken Aoki, Wataru Shigemori, Hiroaki Nakagawa, Daisuke Kinose, Masafumi Yamaguchi, Makoto Osawa, Emiko Ogawa and Yasutaka Nakano
    Citation: Radiation Oncology 2017 12:160
  48. As there is a growing number of long-term cancer survivors, the incidence of carcinogenesis as a late effect of radiotherapy is getting more and more into the focus. The risk for the development of secondary m...

    Authors: Dajana Juerß, Monique Zwar, Ulrich Giesen, Ralf Nolte, Stephan Kriesen, Giorgio Baiocco, Monika Puchalska, Marc-Jan van Goethem, Katrin Manda and Guido Hildebrandt
    Citation: Radiation Oncology 2017 12:159

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions